Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

SYM S043 - New Emerging Therapies

Open admission to eligible categories, no tuition or ticket


Date: Monday, March 24

CME Credits: 3.00

Location: Four Seasons Ballroom 2/3

Time: 2:00 PM - 5:00 PM

Director: Theodore Rosen, MD, FAAD

  • Brian Berman, MD, PhD, FAAD
  • Neal D. Bhatia, MD, FAAD - Handout
  • Boni E. Elewski, MD, FAAD
  • John Strasswimmer, MD, PhD, FAAD
  • Kenneth Yee Tsai, MD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Describe new treatments available for advanced melanoma, keloids and fungal infections
  • Utilize barbed sutures effectively in dermatologic surgery
  • Manage select disease with innovative approaches to therapy

This session is designed to highlight newly approved and soon-to-be available therapeutic interventions for both common and uncommon dermatologic diseases. This will include innovative and off-label treatments.


  • Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma. Oncologist 2013 May 24.
  • New therapeutic options for onychomycosis. Expert Opin Pharmacother 2012 Jun;13(8):1131-42.


Monday, March 24
2:00 PMNew Antifungal Agents / Dr. Elewski
2:30 PMNew Melanoma Drugs / Dr. Tsai
3:00 PMPolypodium: New Photoprotective Agent / Dr. Bhatia
3:30 PMUse of Barbed Sutures / Dr. Strasswimmer
4:00 PMNew Approaches to Scars and Keloids / Dr. Berman
4:30 PMInteresting Innovative Interventions / Dr. Rosen